Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Epigenomics AG announces research collaboration with Stanford University
July 14th, 2006
Epigenomics AG (ECX), a molecular diagnostics company developing tests based on DNA methylation, announced that the company has entered into research collaboration with Stanford University in the field of colorectal cancer. Under the terms of the agreement, Epigenomics and the Molecular Imaging Program at Stanford (MIPS), directed by Dr. Sanjiv Sam Gambhir, will determine potential complementary benefits in the use of DNA methylation markers developed for early detection of colorectal cancer and molecular imaging (FDG PET) in detecting colorectal cancer. Positron emission tomography (PET) is a medical imaging technique which produces a three...
Source: Genomics & Genetics Weekly (2006-07-14)
|
